Last week, a handful of AO employees helped raise thousands of pounds for Kidney Research UK by embarking on a charity walk from the company’s main office in Bolton all the way to the AO Arena.
Setting out on the nearly 30-kilometre walk — 17.6 miles to be exact — nine AO staff members embarked on their journey from the online electrical suppliers’ headquarters over in Bolton to the city centre’s internationally renowned music, entertainment and sporting venue.
Taking them a total of five hours to complete the charity walk, including a short break to stop for ice cream in the hot weather (has to be done, doesn’t it?), they eventually reached their destination and smashed their initial fundraising target of £1,500 in the process.
All told the team of trekkers ended up raising more than £2,600 for Kidney Research, the UK’s leading kidney disease charity, and were treated to a congratulatory glass of champagne upon arriving at the AO Arena’s Electric Lounge. Well deserved.
One of those people is AO affiliate manager, Graham Murray, who spent a number of years on dialysis before his mother donated one of her kidneys to him two years ago and he thankfully underwent a successful transplant.
Having received plenty of support from the organisation in recent years, it was a no-brainer to choose them for the sponsored walk, and both he and his team were delighted to be able to give something back on one of their biannual ‘Make a Difference’ days, where they swap time at their desk for charity and/or community work
ADVERTISEMENT
Still relying on immunosuppression to keep his transplanted kidney healthy, Graham explained how “Kidney Research UK have been very involved in all of [his] treatments so being able to raise so much money for them made the walk more than worth it.”
A big congratulations to our acquisition team 👏
They walked from AO HQ in Bolton to the AO Arena in Manchester to raise money for Kidney Research UK 🥾🗺️
The walk was a mega 28 kilometres, and they celebrated with a glass of champagne at the AO Arena 🥂 pic.twitter.com/ySQYpEvuLb
As for the charity itself, community and events manager Ronan-Peate said: “It is always fantastic to see co-workers come together to take on a great challenge and raise money for charity particularly when it’s one that’s so close to their colleague’s heart.
“The AO employees have completed an amazing achievement and subsequently raised far more than their initial target and we are incredibly grateful for their determination and generosity.
ADVERTISEMENT
“The money that they have raised will go to supporting research to help more people like Graham by transforming treatments and helping us to one day live in a world without kidney disease.” Hear, hear.
It’s brilliant to see AO continuing its incredible charity work in and around Greater Manchester. The AO Smile Foundation is making a huge impact in the community and it doesn’t go unnoticed.
New endometriosis pill helping hundreds of women with ‘debilitating’ condition to be made available on NHS
Emily Sergeant
A groundbreaking new pill to help women with a ‘debilitating’ condition is set to be made available on the NHS.
The new daily pill for endometriosis – which has been approved for use on the NHS in England by the National Institute for Health and Care Excellence (NICE) – is called linzagolix, and will be available for those who have had previous treatment for endometriosis, working to manage any symptoms they may be experiencing.
Around 1.5 million women in the UK are thought to be currently living with endometriosis.
Endometriosis can cause chronic pain, heavy periods, and extreme tiredness when tissue similar to the womb lining grows elsewhere in the body.
A new daily pill for endometriosis has been approved for use on the NHS, and could help over a thousand women in England every year manage the symptoms of the debilitating condition.
As mentioned, linzagolix will be available specifically for patients whose previous medical or surgical treatments for endometriosis have been unsuccessful, and will be given alongside ‘add-back’ hormone therapy – which involves using low-dose hormone replacement therapy (HRT) to prevent menopause-like symptoms and bone loss.
This is the second take-at-home treatment to be approved to treat endometriosis on the NHS, and it’s thought that more than 1,000 women will benefit.
In clinical trials, linzagolix was shown to be successful in reducing painful periods and non-menstrual pelvic pain, compared with placebo, hence why it has been approved on the NHS by NICE.
“This is welcome news for women with endometriosis who haven’t found relief from previous therapies or surgery,” commented Dr Sue Mann, who is the National Clinical Director in Women’s Health for NHS England.
“It’s another treatment option which will help women take control of their health and better manage the symptoms of this often painful and debilitating condition.
“This is a testament to our ongoing commitment to improving treatment, care and quality of life for women.”
Featured Image – Heute
News
Wigan woman jailed after hitting pedestrian in Fiat 500 while driving high on nitrous oxide ‘balloons’
Emily Sergeant
A young woman from Wigan has been handed jail time after hitting a pedestrian while driving high on nitrous oxide.
Louisa Tunstall was driving a white Fiat 500 towards the East Lancashire Road in Wigan at around 7pm on Friday 24 May 2024 – a time when traffic conditions were said to be ‘quiet’ – but Tunstall was under the influence of a now-banned drug, nitrous oxide, at the time of the incident, Greater Manchester Police (GMP) confirmed.
While driving under the influence, 19-year-old Tunstall veered to the left onto the pavement and collided with a 51-year-old woman pedestrian.
After striking the woman, the car then overturned and, in the process, caused serious life-changing injuries.
When questioned by police, Tunstall stated that she ‘took her eyes off the road’ to retrieve something in the footwell before knowing the car had flipped, but she also confirmed that she had just been out to purchase nitrous oxide to use that evening.
After obtaining witness accounts, investigating officers were able to track down nearby CCTV footable which showed Tunstall inhaling nitrous oxide through a balloon whilst driving, seconds before the collision occurred.
#JAILED | It's not a laughing matter when you get behind the wheel under the influence of drugs.
Now Louisa Tunstall has to spend over a year behind bars after inhaling nitrous oxide and causing serious injury in #Wigan last year.
— Greater Manchester Police (@gmpolice) May 14, 2025
Further investigation by GMP’s Forensic Vehicle Examination Unit examined the Fiat 500 and confirmed that no defects were found on the car to contribute towards the collision.
Still to this day, the victim says she is trying to recover from the injuries sustained to her leg that will prevent her from continuing life as she did before.
“The incident is still very raw when I think about it,” the victim explained in her impact statement released by GMP. “I become upset when I think at everything which has been taken away from me and the ongoing affect it has had and continues to have on my daily life.”
GMP says it’s seeing the use of nitrous oxide being a factor in incidents they attend increasing year on year.
Nitrous oxide, also known as ‘laughing gas’, is reported to produce euphoria, relaxation, dizziness, giggling or laughing fits, impaired judgement, and occasionally dissociation and hallucinations – which GMP says affects reaction time and and is ‘likely lead to impairment’ in driving performance, particularly when faced with an unexpected or hazardous situation.
Tunstall appeared at Bolton Crown Court this week, and has been sentenced to one year and eight months imprisonment for having possession of a Class C drug, driving under the influence of drugs, and causing serious injury by dangerous driving.
Alongside being jailed, she was also disqualified from driving for two years and eight months, and has been ordered to take an extended test when she is released.
Danny Jones -
1st August 2023 
